HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Matti Aapro Selected Research
Matti Aapro Research Topics
Disease
71
Neoplasms (Cancer)
12/2023 - 01/2002
53
Nausea
03/2024 - 01/2004
53
Vomiting
12/2023 - 01/2004
31
Breast Neoplasms (Breast Cancer)
04/2024 - 01/2002
18
Anemia
01/2019 - 10/2006
15
Febrile Neutropenia
01/2022 - 02/2008
12
Neutropenia
02/2024 - 06/2010
10
Chemotherapy-Induced Febrile Neutropenia
06/2019 - 05/2010
9
Neoplasm Metastasis (Metastasis)
06/2019 - 03/2007
4
Fatigue
01/2021 - 08/2014
4
Prostatic Neoplasms (Prostate Cancer)
10/2017 - 04/2012
4
Osteonecrosis (Kienbock's Disease)
10/2012 - 03/2007
3
Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2017
3
Alopecia (Baldness)
01/2021 - 04/2016
3
Multiple Myeloma
04/2012 - 01/2010
2
COVID-19
01/2022 - 01/2021
2
Dyspnea (Shortness of Breath)
01/2021 - 06/2019
2
Infections
01/2021 - 10/2017
2
Hypersensitivity (Allergy)
01/2021 - 01/2020
2
Hemorrhage
01/2021 - 04/2011
2
Hematologic Neoplasms (Hematological Malignancy)
12/2019 - 03/2019
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2019 - 05/2007
2
Hypertension (High Blood Pressure)
06/2019 - 05/2011
2
Disease Progression
06/2019 - 01/2002
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2018 - 03/2018
2
Iron Deficiencies
12/2015 - 01/2014
2
Osteoporosis
08/2014 - 04/2012
1
Chronic Kidney Failure (Chronic Renal Failure)
01/2023
1
Sepsis (Septicemia)
01/2021
1
Injection Site Reaction
01/2021
Drug/Important Bio-Agent (IBA)
26
Antiemetics
IBA
03/2024 - 01/2004
22
Biosimilar Pharmaceuticals
IBA
04/2024 - 03/2011
17
Palonosetron (Aloxi)
FDA Link
03/2024 - 01/2004
16
Dexamethasone (Maxidex)
FDA Link
Generic
03/2024 - 02/2005
14
Filgrastim (Neupogen)
FDA Link
02/2024 - 03/2011
14
Anthracyclines
IBA
01/2021 - 01/2002
14
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2021 - 02/2003
9
Cisplatin (Platino)
FDA Link
Generic
03/2024 - 01/2008
9
netupitant
IBA
03/2024 - 01/2015
9
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2022 - 02/2008
9
Hematinics
IBA
01/2019 - 02/2007
6
Epoetin Alfa (Epogen)
FDA Link
01/2023 - 01/2014
6
Aprepitant (Emend)
FDA Link
01/2023 - 01/2004
6
5-HT3 Serotonin Receptors (5 HT3 Receptor)
IBA
01/2021 - 01/2004
5
Hormones (Hormone)
IBA
01/2022 - 04/2011
5
Neurokinin-1 Receptor Antagonists
IBA
01/2021 - 04/2016
5
Diphosphonates (Bisphosphonates)
IBA
04/2012 - 03/2007
5
epoetin beta
IBA
11/2009 - 01/2004
4
pegfilgrastim (Neulasta)
FDA Link
06/2020 - 06/2010
4
taxane
IBA
06/2019 - 01/2004
4
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2017 - 06/2005
4
Iron
IBA
11/2016 - 01/2014
4
Zoledronic Acid (Zometa)
FDA Link
04/2012 - 03/2007
3
human ERBB2 protein
IBA
04/2024 - 01/2022
3
Olanzapine (Zyprexa)
FDA Link
08/2021 - 03/2020
3
Colony-Stimulating Factors (Colony Stimulating Factor)
IBA
06/2019 - 05/2010
3
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2017 - 02/2003
3
Serotonin (5 Hydroxytryptamine)
IBA
01/2017 - 07/2005
3
Granisetron (Kytril)
FDA Link
Generic
08/2016 - 01/2004
3
Denosumab
FDA Link
04/2012 - 01/2010
3
Docetaxel (Taxotere)
FDA Link
10/2011 - 01/2002
3
Proteins (Proteins, Gene)
FDA Link
07/2010 - 02/2007
2
Trastuzumab (Herceptin)
FDA Link
04/2024 - 02/2004
2
Antineoplastic Agents (Antineoplastics)
IBA
12/2023 - 01/2014
2
Carboplatin (JM8)
FDA Link
Generic
01/2021 - 08/2016
2
Paclitaxel (Taxol)
FDA Link
Generic
06/2019 - 10/2011
2
Vinorelbine (Navelbine)
FDA Link
Generic
06/2019 - 04/2012
2
Antibodies
IBA
10/2017 - 01/2017
2
Radiopharmaceuticals
IBA
01/2017 - 05/2012
2
Substance P
IBA
01/2017 - 06/2005
2
rolapitant
IBA
01/2017 - 08/2016
2
Hemoglobins (Hemoglobin)
IBA
04/2013 - 10/2006
2
Creatinine
IBA
05/2012 - 03/2012
2
Aromatase Inhibitors
IBA
04/2011 - 07/2007
2
Pamidronate (Aredia)
FDA Link
Generic
01/2010 - 03/2007
2
Vincristine (Oncovin)
FDA Link
Generic
01/2009 - 02/2003
2
liposomal doxorubicin (Doxil)
FDA Link
04/2008 - 01/2007
2
Erythropoietin
FDA Link
02/2008 - 01/2004
2
Capecitabine (Xeloda)
FDA Link
01/2002 - 01/2002
1
Ogivri
IBA
04/2024
1
Emetics
IBA
12/2023
1
ErbB Receptors (EGF Receptor)
IBA
12/2022
1
phytobacteriomycin (PBM)
IBA
01/2022
1
Phenobarbital (Luminal)
FDA Link
01/2022
1
Platinum
IBA
01/2021
1
Etoposide (VP 16)
FDA Link
Generic
01/2021
1
Topotecan (Hycamtin)
FDA Link
Generic
01/2021
1
trilaciclib
IBA
01/2021
Therapy/Procedure
101
Drug Therapy (Chemotherapy)
03/2024 - 01/2002
37
Therapeutics
12/2022 - 01/2002
7
Radiotherapy
01/2023 - 01/2002
4
Adjuvant Chemotherapy
06/2019 - 06/2005
3
Palliative Care (Palliative Therapy)
01/2021 - 12/2017
2
Hematopoietic Stem Cell Mobilization
02/2024 - 12/2019
2
Chemoradiotherapy
01/2019 - 01/2008
2
Activities of Daily Living (ADL)
12/2017 - 10/2017
2
Castration
10/2017 - 01/2017
2
Combination Drug Therapy (Combination Chemotherapy)
01/2008 - 07/2004
1
Length of Stay
01/2022
1
Ambulatory Care (Outpatient Care)
01/2022